Patterns of glycaemic control in Australian primary care (NEFRON 8)

Internal Medicine Journal

Volumn 39, Issue 8, 2009, Pages 512-518

  MacIsaac, R J ^a,d   Jerums, G ^a   Weekes, A J ^b   Thomas, M C ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d HEIDELBERG REPATRIATION HOSPITAL   (Australia)

Author keywords

Australia; Blood glucose; Diabetes mellitus; Glycaemic control; Primary care

Indexed keywords

GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; AUSTRALIA; CONTROLLED STUDY; FEMALE; GENERAL PRACTICE; GLYCEMIC CONTROL; HUMAN; KIDNEY DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; AGED; AUSTRALIA; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLYCEMIC INDEX; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE;

EID: 65549094512     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01821.x     Document Type: Article

References (22)

1. Harris P, Mann L, Phillips P, eds. Diabetes Management in General Practice 2007/8, 13th edn. Sydney : Diabetes Australia and the Royal Australian College of General Practitioners 2008.
2. Standards of medical care in diabetes 2008. Diabetes Care 2008 31 (Suppl 1 S12 54.
3. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2006 49 : 1711 1721. (Pubitemid 44025023)
4. Yue DK, Colagiuri S, McElduff A, Silink M. Diabetes Control and Complications Trial. Position statement of the Australian Diabetes Society. Med J Aust 1993 159 : 803 804.
5. Thomas MC, Weekes AJ, Broadley OJ, Cooper ME, Mathew TH. The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Med J Aust 2006 185 : 140 144.
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study Group. Lancet 1998 352 : 837 853.
7. Kemp TM, Barr EL, Zimmet PZ, Cameron AJ, Welborn TA, Colagiuri S et al. Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: the 1999-2000 AusDiab. Diabetes Care 2005 28 : 1490 1492.
8. Bryant W, Greenfield JR, Chisholm DJ, Campbell LV. Diabetes guidelines: easier to preach than to practise? Med J Aust 2006 185 : 305 309.
9. Yong TY, Phillipov G, Phillips PJ. Management outcomes of patients with type 2 diabetes: targeting the 10-year absolute risk of coronary heart disease. Med J Aust 2007 186 : 622 624.
10. Thomas M, Weekes AJ, Thomas MC. The management of diabetes in indigenous Australians from primary care. BMC Public Health 2007 7 : 303.
11. O'Dea K, Rowley KG, Brown A Diabetes in Indigenous Australians: possible ways forward. Med J Aust 2007 186 : 494 495.
12. Del Prato S, Felton AM, Munro N, Nesto R, Zimmet P, Zinman B. Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Int J Clin Pract 2005 59 : 1345 1355.
13. Consensus statement for guidelines on glycemic control. Endocr Pract 2002 8 (Suppl. 1 40 82.
14. Glucose control levels. Global Guidelines for Type 2 Diabetes, Ch. 6. Brussels: International Diabetes Federation 2005 26 8.
15. Gerstein HC, Miller ME, Byington RP, Goff DC Jr., Bigger JT, Buse JB et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 358 : 2545 2559.
16. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 358 : 2560 2572.
17. Home P. Safety of very tight blood glucose control in type 2 diabetes. Diabetes 2008 336 : 458 459.
18. Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med 2008 358 : 2630 2633.
19. Cefalu WT. Glycemic targets and cardiovascular disease. N Engl J Med 2008 358 : 2633 2635.
20. Davis TM, Davis WA, Bruce DG. Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study. Med J Aust 2006 184 : 325 328.
21. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006 29 : 1963 1972. (Pubitemid 44156663)
22. Cohen ND, Shaw JE. Diabetes: advances in treatment. Intern Med J 2007 37 : 383 388.